Try searching for...
Interactions between compounds and specific gene/protein targets.
| BIMP_ID | Target Name | Gene | Organism | Action | Source URL |
|---|---|---|---|---|---|
|
HTR2C
|
Homo sapiens (human)
|
LSH acts as an agonist at 5-HT2 receptors, causing direct stimulation of the uterine smooth musculature, resulting in increased muscular tone and an enhancement of the rate and force of rhythmical contractions. (A2919)
|
http://www.t3db.ca/biodb/bio_entities/BE0000533
|
||
|
HTR2C
|
Homo sapiens (human)
|
Lysergol moderates the activity of the serotonin and noradrenergic systems of the brain by acting as an antagonist and partial agonist of 5-HT receptors. this also causes vasoconstriction. (A2925, A2931)
|
http://www.t3db.ca/biodb/bio_entities/BE0000533
|
||
|
HTR2C
|
Homo sapiens (human)
|
|
http://www.t3db.ca/biodb/bio_entities/BE0000533
|
||
|
HTR2C
|
Homo sapiens (human)
|
Psilocybin is rapidly dephosphorylated in the body to psilocin which then acts as a partial agonist at the 5-HT2A serotonin receptor in the brain where it mimics the effects of serotonin (5-HT). psilocin is an 5-HT1A and 5-HT2A/2C agonist. (L1143)
|
http://www.t3db.ca/biodb/bio_entities/BE0000533
|
||
|
HTR2C
|
Homo sapiens (human)
|
Bufotenin is a neurotoxin similar to the mushroom toxin psilocin. thus it likely acts as a partial agonist at the 5-HT2A serotonin receptor in the brain where it mimics the effects of serotonin (5-HT). it is likely also a 5-HT1A and 5-HT2A/2C agonist. (L1081, L1673)
|
http://www.t3db.ca/biodb/bio_entities/BE0000533
|
||
|
HTR2C
|
Homo sapiens (human)
|
|
http://www.t3db.ca/biodb/bio_entities/BE0000533
|
||
|
HTR2C
|
Homo sapiens (human)
|
Antagonist
|
https://www.drugbank.ca/bio_entities/BE0000533
|
||
|
HTR2C
|
Homo sapiens (human)
|
Ergometrine acts as an agonist at 5-HT2 receptors, causing direct stimulation of the uterine smooth musculature, resulting in increased muscular tone and an enhancement of the rate and force of rhythmical contractions. (A2915)
|
http://www.t3db.ca/biodb/bio_entities/BE0000533
|
||
|
HTR2C
|
Homo sapiens (human)
|
|
http://www.t3db.ca/biodb/bio_entities/BE0000533
|
||
|
HTR2C
|
Homo sapiens (human)
|
|
http://www.t3db.ca/biodb/bio_entities/BE0000533
|
||
|
HTR2C
|
Homo sapiens (human)
|
Antagonist|Downregulator
|
https://www.drugbank.ca/bio_entities/BE0000533
|
||
|
Htr2c
|
Rattus norvegicus (Norway rat)
|
Antagonist
|
https://www.drugbank.ca/bio_entities/BE0004882
|
||
|
HTR2C
|
Homo sapiens (human)
|
Agonist
|
https://www.drugbank.ca/bio_entities/BE0000533
|
||
|
HTR2C
|
Homo sapiens (human)
|
Ergotamine acts as an agonist at 5-HT2 receptors, causing vasoconstriction. (A1505, A1506, A365)
|
http://www.t3db.ca/biodb/bio_entities/BE0000533
|
||
|
HTR2C
|
Homo sapiens (human)
|
|
http://www.t3db.ca/biodb/bio_entities/BE0000533
|
||
|
HTR2C
|
Homo sapiens (human)
|
|
https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3430
|
||
|
HTR3A
|
Homo sapiens (human)
|
|
https://www.drugbank.ca/bio_entities/BE0000311
|
||
|
HTR3A
|
Homo sapiens (human)
|
|
http://www.t3db.ca/biodb/bio_entities/BE0000311
|
||
|
HTR3A
|
Homo sapiens (human)
|
|
https://www.drugbank.ca/bio_entities/BE0000311
|
||
|
HTR3A
|
Homo sapiens (human)
|
Antagonist
|
https://www.drugbank.ca/bio_entities/BE0000311
|
||
|
HTR3A
|
Homo sapiens (human)
|
Antagonist
|
https://www.drugbank.ca/bio_entities/BE0000311
|
||
|
HTR3A
|
Homo sapiens (human)
|
|
http://www.t3db.ca/biodb/bio_entities/BE0000311
|
||
|
HTR3A
|
Homo sapiens (human)
|
|
http://www.t3db.ca/biodb/bio_entities/BE0000311
|
||
|
HTR3A
|
Homo sapiens (human)
|
Antagonist
|
https://www.drugbank.ca/bio_entities/BE0000311
|
||
|
HTR3A
|
Homo sapiens (human)
|
Antagonist
|
https://www.drugbank.ca/bio_entities/BE0000311
|
No matching records found on this page.